Clinical studies have also reported increased HMGB-1 serum levels in patients with CAD [85,86], peripheral artery [87] and HHcy [88], suggesting that HMGB-1 has a critical pathogenic role during development and progression of CVDs. Here, HMGB1 is linked to coronary artery disorder.